<acronym id="4i8k8"></acronym><rt id="4i8k8"><xmp id="4i8k8">
<rt id="4i8k8"></rt><rt id="4i8k8"></rt><rt id="4i8k8"></rt><rt id="4i8k8"></rt>
<acronym id="4i8k8"></acronym>
<tr id="4i8k8"><xmp id="4i8k8">
<sup id="4i8k8"><optgroup id="4i8k8"></optgroup></sup>
<rt id="4i8k8"><xmp id="4i8k8">

Cboe - Market News

1 2 3 > >>
1/15/2020 3:02:15 PM

GeneTx And Ultragenyx Announce Investigational New Drug Application Is Now Active Active For GTX-102 In Patients with Angelman Syndrome; Enrollment In First Phase 1/2 Study Expected To Begin In 1H 2020

Channels: News | Biotech | FDA | General
Symbols: RARE
1/15/2020 9:48:28 AM

From JP Morgan Healthcare Conference: AbbVie CEO Sees Humira Continuing To Grow In US Through The Time It Loses Market Exclusivity

Channels: Guidance | News | Eurozone | FDA | Markets
Symbols: ABBV | ABBV
1/15/2020 9:22:56 AM

FDA Grants Priority Review Designation For Clovis Oncology's Rubraca Label Expansion

Channels: News | Biotech | FDA | Movers | Trading Ideas
Tags: Rubraca
Symbols: CLVS
1/15/2020 8:07:15 AM

Nektar Slumps As FDA Panel Gives Thumbs Down To Opioid Pain Drug; Program Shelved

Channels: News | Biotech | FDA | Movers | Trading Ideas
Tags: Opioids
Symbols: NKTR | IPCIF
1/15/2020 7:31:13 AM

Novavax Granted Fast Track Designation For NanoFlu In Older Adults

Channels: News | Biotech | FDA | General
Symbols: NVAX
1/15/2020 7:22:46 AM

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance

Channels: News | Biotech | Guidance | FDA | Trading Ideas
Symbols: ALPMY | ADAP | APLT | ARVN | ATHX | ATRC | BVXV | CALA | EDIT | EPZM | FATE | FREQ | GLPG | GNMK | HALO | HOLX | IART | IBB | IPCIF | LLY | MEDP | MNTA | MYOK | NEO | NKTR | NOVN | NUVA | NVO | PROF | PTLA | RCEL | REPL | RGEN | RMTI | RVNC | SLS | STML | SYNH | TGTX | VAR | VIE | WST | XBI | XBIT | ZLAB | ZTS
1/15/2020 7:02:44 AM

Clovis Oncology's Rubraca Granted FDA Priority Review For Advanced Prostate Cancer

Channels: News | Biotech | FDA | General
Symbols: CLVS
1/15/2020 6:06:35 AM

FDA Accepts For Priority Review Bristol-Myers Squibb's Application For Opdivo Plus Yervoy In First-Line Non-Small Cell Lung Cancer

Channels: News | Biotech | FDA | General
Symbols: BMY
1/15/2020 6:04:34 AM

Neovasc Receives Administrative Acceptance Review Notification For Premarket Approval Application From FDA For The Neovasc Reducer

Channels: News | Biotech | FDA | General
Symbols: NVCN
1/14/2020 5:24:55 PM

Lannett Shares Jolted By FDA Approval Of Cocaine Spray For Nasal Surgery

Channels: News | Cannabis | Health Care | FDA | Markets | General
Tags: Numbrino
Symbols: LCI
1/14/2020 3:36:11 PM

Hearing FDA AdCom Panel Has Unanimously Voted Against Approval Of Nektar's Opioid Painkiller

Channels: Rumors | News | FDA | Movers | Trading Ideas
Symbols: NKTR
1/14/2020 3:16:48 PM

Hearing Nektar After-Hours Downside Attributed To Comments From AdCom Panel On Oxycodegol Suggested Data Obtained From 1 Study Not Substantial Enough To Support Proposed Use

Channels: Rumors | News | FDA | Movers | Trading Ideas
Symbols: NKTR
1/14/2020 3:14:41 PM

Nektar Therapeutics Shares Down 20% On Heavy After-Hours Volume; FDA AdCom Panel Meeting On Co.'s Oxycodegol Currently Underway

Channels: FDA | News | Movers | Trading Ideas
Symbols: NKTR
1/14/2020 1:32:17 PM

Eloxx Pharma Offers Update On Progress Of Phase 2 Programs For ELX-02, ERSG Pipeline: Sees ELX-02 Fully Enrolled In Q1'20, Topline Results In 1H'20

Channels: Guidance | News | FDA
Symbols: ELOX
1/14/2020 1:22:48 PM

From JP Morgan Healthcare Conference: GW Pharma CEO Sees Filing Application For Expanded US Approval Of Epilepsy Drug 'In Coming Week's

Channels: Rumors | News | FDA
Symbols: GWPH
1/14/2020 7:48:10 AM

Abbvie's SKYRIZI Met Barth Primary And All Ranked Secondary Endpoints In Phase 3 Study

Channels: News | Biotech | FDA | General
Symbols: ABBV | ABBV
1/14/2020 7:03:38 AM

Biocardia Announces FDA Clearance For Morph DNA Deflectable Guide Catheter

Channels: News | Biotech | FDA | General
Symbols: BCDA
1/14/2020 6:55:40 AM

The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug

Channels: News | Biotech | Guidance | FDA | Trading Ideas
Symbols: NVO | OYST | PAVM | PHAS | QGEN | RGEN | RMD | RVNC | SLRX | SLS | STML | TRPX | VERU | VIE | WST | XBI | XERS | ZTS | ADAP | ACST | ALPMY | AMGN | ANIX | ARVN | ATHE | BAX | BMY | BVXV | CFRX | COLL | EKSO | EOLS | FENC | FULC | GH | GOSS | HZNP | IBB | INSP | ITMR | LLY | LMAT | MASI | MESO | MTEM | NEO | NK | NKTR | NOVN | NUVA
1/14/2020 5:56:47 AM

TransEnterix Announces Submission Of 510(k) To FDA For First Machine Vision System In Robotic Surgery

Channels: Bonds | News | FDA | Markets
Symbols: TRXC
1/13/2020 11:48:07 AM

Sarepta Therapeutics Inc Says Last Friday Filed Rolling Submission For Approval Of DMD Therapy Casimersen

Channels: News | Biotech | FDA | General
Symbols: SRPT
1/13/2020 9:24:39 AM

BioCardia Receives FDA 510k Approval For 8F Morph DNA Deflectable Guide Catheter

Channels: News | Biotech | FDA | General
Symbols: BCDA
1/13/2020 7:24:56 AM

Aravive Receives Investigational New Drug Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma

Channels: FDA | News
Symbols: ARAV
1/13/2020 7:24:30 AM

Ultragenyx and Kyowa Kirin Submit Supplemental Biologics License Application to FDA for Crysvita for Tumor-Induced Osteomalacia

Channels: FDA | News
Symbols: RARE
1/13/2020 7:22:05 AM

Horizon Therapeutics Announces 79% Of Patients Achieved A Complete Response In MIRROR Open-Label Pilot Study, Supporting KRYSTEXXA Immunomodulation Strategy To Optimize Treatment Outcomes

Channels: News | Biotech | FDA | General
Symbols: HZNP
1/13/2020 7:18:30 AM

Checkpoint Therapeutic Receives FDA Feedback Confirming Co.'s Registration Path For Cosibelimab In Metastatic Cutaneous Squamous Cell Carcinoma Based On Efficacy And Safety Data From Phase 1 Clinical Trial

Channels: News | Biotech | FDA | General
Symbols: CKPT
福彩快3走势图一定牛